The encapsulation efficiency was 89.42 ± 0.77% (1%‐Axitinib), 85.15 ± 1.72% (3%‐Axitinib), and 80.67 ± 0.65% (6%‐Axitinib), and showed a decreasing trend with increasing axitinib content.
← all excerpts
An Avascular Niche Created by Axitinib-Loaded PCL/Collagen Nanofibrous Membrane Stabilized Subcutaneous Chondrogenesis of Mesenchymal Stromal Cells.
1
—
—